Clinical Management of Hyperkalemia.

Chelating Agents / therapeutic use Disease Management Humans Hyperkalemia / blood Potassium / blood Renin-Angiotensin System Silicates / therapeutic use Time Factors Treatment Outcome

Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
03 2021
Historique:
received: 27 02 2020
revised: 18 05 2020
accepted: 10 06 2020
pubmed: 9 11 2020
medline: 23 3 2021
entrez: 8 11 2020
Statut: ppublish

Résumé

Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences. Despite various guidelines, no universally accepted consensus exists on best practices for hyperkalemia monitoring, with variations in precise potassium (K

Identifiants

DOI: 10.1016/j.mayocp.2020.06.014 PMID: 33160639
pubmed: 33160639
pii: S0025-6196(20)30618-2
doi: 10.1016/j.mayocp.2020.06.014
pii:
doi:

Substances chimiques

Chelating Agents 0
Silicates 0
sodium zirconium cyclosilicate D652ZWF066
Potassium RWP5GA015D

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

744-762

Informations de copyright

Copyright © 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Biff F Palmer (BF)

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas. Electronic address: biff.palmer@utsouthwestern.edu.

Juan Jesus Carrero (JJ)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Deborah J Clegg (DJ)

Drexel University College of Nursing and Health Professions, Philadelphia, PA.

Gates B Colbert (GB)

Baylor University Medical Center, Dallas, TX.

Michael Emmett (M)

Baylor University Medical Center, Dallas, TX.

Steven Fishbane (S)

Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.

Debra J Hain (DJ)

Christine E. Lynn College of Nursing, Florida Atlantic University, and Cleveland Clinic Florida, Weston, FL.

Edgar Lerma (E)

Department of Medicine, University of Illinois at Chicago/Advocate Christ Medical Center, Oak Lawn.

Macaulay Onuigbo (M)

Robert Larner College of Medicine, University of Vermont Medical Center, Burlington.

Anjay Rastogi (A)

David Geffen School of Medicine, University of California, Los Angeles.

Simon D Roger (SD)

Renal Research, Gosford Hospital, Gosford, Australia.

Bruce S Spinowitz (BS)

Nephrology Associates P.C., New Rochelle, NY.

Matthew R Weir (MR)

Department of Medicine, University of Maryland School of Medicine, Baltimore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Agents séquestrants › Chélateurs › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Troubles de l'équilibre hydroélectrolytique › Hyperkaliémie › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux légers › Potassium › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Hémodynamique › Système rénine-angiotensine › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Produits chimiques inorganiques › Composés du silicium › Silice › Acide silicique › Silicates › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › Clinical Management of Hyperkalemia.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Clinical Management of Hyperkalemia.